Clinical Trials Study
Copyright ©2014 Baishideng Publishing Group Inc.
World J Hepatol. Jul 27, 2014; 6(7): 513-519
Published online Jul 27, 2014. doi: 10.4254/wjh.v6.i7.513
Table 1 Patients’ first assessment demographic and clinical characteristics
PatientsGenderAge (yr)Primary colonic tumour locationMetastatic type (liver-limited)Colonic obstruction > stent placement
1Male67SigmoidII-
2Male75SigmoidII-
3Female37SigmoidIII-
4Male79SigmoidIII
5Male79DescendingIII
6Male40SigmoidII
7Female75SigmoidII-
8Male59DescendingIII-
9Female78DescendingIII
10Male59SigmoidIII
11Male75AscendingII-
Table 2 Patients’ operative treatment and oncologic characteristics
PatientsMetastatic type (liver-limited)Hepatectomy 1Hepatectomy 2ColectomyDisease-free
Overall
Survival period (mo)
1IIRE and wedge and RFA-MWA-8.2339.57
2IIRightLeft lateral and RFA-MWA2.2014.17
3III----13.97
4III----7.33
5III----13.37
6IILaparoscopic left lateralRight15.2739.17
7IILeft lateralRight5.2715.57
8III----9.43
9IIILaparoscopic left lateral---7.80
10III----11.5
11II----10.1